Androgenetic Alopecia Treatment Using Varin and Cannabidiol Rich Topical Hemp Oil: A Case Series

Status unconfirmed · Early Phase 1

Conditions studied: Androgenetic Alopecia

In brief

This is a case series of adult, male and female subjects with androgenetic alopecia (male pattern baldness). A topical hemp oil that is rich in varins (THCV and CBDV) and cannabidiol (CBD) is being used daily for six months to stimulate hair regrowth using Endocannabinoid System (ECS) receptors that are found on hair follicles.

Key facts

Study ID

NCT04842383

Run by

Gregory L Smith, MD, MPH

People needed

40

Starts

2021-04-05

Expected to finish

2021-10-04

Last updated by the study team

2021-04-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 18 or older
• Physician-diagnosed androgenetic alopecia (AGA) with Norwood-Hamilton Classification score of 3V or higher.
• Not currently using minoxidil or finasteride.
• Agree to complete six months of the study.
• Agreed to not use other hair loss treatments, including minoxidil and/or finasteride during the six months of the study.
• Agrees to and signs Informed Consent Form.

You may not qualify if…

• Inability to meet the 'Inclusion Criteria' above.

Where it is running

• Hair and Scalp Clinic — Clearwater, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.